New oral anticoagulants and oculoplastic surgery.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2014 Vol.49(2) p. 123-7

Ing E, Douketis J

관련 도메인

Abstract

The use of oral anticoagulants is increasing because of the rising prevalence of atrial fibrillation and other cardiovascular diseases that occur in an aging population. In the last decade, several new oral anticoagulants have emerged, comprising the direct thrombin inhibitor dabigatran and the factor Xa inhibitors apixaban and rivaroxaban. Although these new anticoagulants may not affect clear corneal cataract surgery, their use will impact the management of patients having eyelid, orbital, and nasolacrimal procedures. The objective of this review is to provide a concise and practical approach to the perioperative management of patients who require an oculoplastic procedure and are receiving these new anticoagulants.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 eyelid 눈꺼풀 dict 1
해부 oral scispacy 1
해부 oral anticoagulants scispacy 1
해부 corneal scispacy 1
해부 nasolacrimal scispacy 1
약물 dabigatran C2348066
dabigatran
scispacy 1
약물 apixaban C1831808
apixaban
scispacy 1
약물 rivaroxaban C1739768
rivaroxaban
scispacy 1
질환 atrial fibrillation C0004238
Atrial Fibrillation
scispacy 1
질환 cardiovascular diseases C0007222
Cardiovascular Diseases
scispacy 1
질환 corneal cataract scispacy 1
기타 thrombin scispacy 1

MeSH Terms

Administration, Oral; Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Cataract Extraction; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Surgery, Plastic; Thiophenes; beta-Alanine

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문